DOSSIER · 13F Holders · Q4 2025
PROTAGONIST THERAPEUTICS
21 institutions still hold PROTAGONIST THERAPEUTICS as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 74366E106·21 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
21 institutions reported PROTAGONIST THERAPEUTICS in Q4 2025. MARSHALL WACE, LLP leads at 60.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
1 more holders available. Log in →